Drug Interaction Study of Darunavir/Ritonavir and Lopinavir/Ritonavir on GSK2248761 PK and CYP450 Probe Drugs
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of GSK2448761 on CYP450 metabolic probes
and to evaluate the 2-way interaction between GSK2448761 and two ritonavir-boosted protease
inhibitors that are commonly used in HIV-infected subjects.